DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose

References

• Group IDFDA. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract. 2015;109(3):461–465.
   PubMed Web of Science ®Google Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–1101.
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523.
   PubMed Web of Science ®Google Scholar
• Yang L, Shao J, Bian Y, et al. Prevalence of type 2 diabetes mellitus among inland residents in China (2000-2014): a meta-analysis. J Diabetes Investig. 2016;7(6):845–852.
   PubMed Web of Science ®Google Scholar
• Helou N, Dwyer A, Burnier M, et al. Multidisciplinary management of diabetic kidney disease: a systematic review protocol. JBI Evidence Synthesis. 2014;12(7):192–203.
   Google Scholar
• de Boer IH. A new chapter for diabetic kidney disease. N Engl J Med. 2017;377(9):885–887.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959.
   PubMed Web of Science ®Google Scholar
• Tahara A, Takasu T. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice. Eur J Pharmacol. 2018;830:68–75.
   PubMed Web of Science ®Google Scholar
• Kim MK. Treatment of diabetic kidney disease: current and future targets. Korean J Intern Med. 2017;32(4):622–630.
   PubMed Web of Science ®Google Scholar
• Jing G, Hongdong C, Xiyan Z, et al. Diabetic kidney disease treated with a modified Shenzhuo formula derived from Traditional Chinese Medicine: a case report. J Tradit Chin Med. 2017;37(6):854–861.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang Y, Wu H, et al. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci. 2004;95(2):256–266.
   PubMed Web of Science ®Google Scholar
• Huang W, Huang J, Liu Q, et al. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol. 2015;82(2):229–233.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim SS, Kim IJ, et al. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients. J Diabetes Complications. 2012;26(4):308–312.
   PubMed Web of Science ®Google Scholar
• Zhou JY, Xu B, Li L. A new role for an old drug: metformin targets microRNAs in treating diabetes and cancer. Drug Dev Res. 2015;76(6):263–269.
   PubMed Web of Science ®Google Scholar
• Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem. 2013;54:29–38.
   PubMed Web of Science ®Google Scholar
• Guo J, Li J, Zhao J, et al. MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin. Sci Rep. 2017;7(1):2314.
   PubMed Web of Science ®Google Scholar
• Sun T, Liu Y, Liu L, et al. MicroRNA-544 attenuates diabetic renal injury via suppressing glomerulosclerosis and inflammation by targeting FASN. Gene. 2020;723:143986.
   PubMed Web of Science ®Google Scholar
• Rovira-Llopis S, Escribano-Lopez I, Diaz-Morales N, et al. Downregulation of miR-31 in diabetic nephropathy and its relationship with inflammation. Cell Physiol Biochem. 2018;50(3):1005–1014.
   PubMedGoogle Scholar
• Li M, Guo Q, Cai H, et al. miR-218 regulates diabetic nephropathy via targeting IKK-beta and modulating NK-kappaB-mediated inflammation. J Cell Physiol. 2020;235(4):3362–3371.
   PubMed Web of Science ®Google Scholar
• Li L, Zhu Z, Zhao Y, et al. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Sci Rep. 2019;9(1):7827.
   PubMedGoogle Scholar
• Su SS, Li BP, Li CL, et al. Downregulation of MiR-218 can alleviate high-glucose-induced renal proximal tubule injury by targeting GPRC5A. Biosci Biotechnol Biochem. Advance online publication.
   Web of Science ®Google Scholar
• Yang H, Wang Q, Li S. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1. Biochem Biophys Res Commun. 2016;471(4):582–588.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang H, Zhang K, et al. miRNA-216 and miRNA-499 target cyb561d2 in zebrafish in response to fipronil exposure. Environ Toxicol Pharmacol. 2016;45:98–107.
   PubMed Web of Science ®Google Scholar
• Endlich N, Kliewe F, Kindt F, et al. The transcription factor Dach1 is essential for podocyte function. J Cell Mol Med. 2018;22(5):2656–2669.
   PubMed Web of Science ®Google Scholar
• Sangoi MB, de Carvalho JA, Tatsch E, et al. Urinary inflammatory cytokines as indicators of kidney damage in type 2 diabetic patients. Clin Chim Acta. 2016;460:178–183.
   PubMed Web of Science ®Google Scholar
• Kanasaki K, Taduri G, Koya D. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol. 2013;4:7.
   PubMedGoogle Scholar
• Wasik AA, Lehtonen S. Glucose transporters in diabetic kidney disease-friends or foes? Front Endocrinol. 2018;9:155.
   PubMed Web of Science ®Google Scholar
• Higgins GC, Coughlan MT. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol. 2014;171(8):1917–1942.
   PubMed Web of Science ®Google Scholar
• Alvarez ML, DiStefano JK. Towards microRNA-based therapeutics for diabetic nephropathy. Diabetologia. 2013;56(3):444–456.
   PubMed Web of Science ®Google Scholar
• Li D, Lu Z, Jia J, et al. Changes in microRNAs associated with podocytic adhesion damage under mechanical stress. J Renin Angiotensin Aldosterone Syst. 2013;14(2):97–102.
   PubMed Web of Science ®Google Scholar
• Mu J, Pang Q, Guo YH, et al. Functional implications of microRNA-215 in TGF-beta1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS One. 2013;8(3):e58622.
   PubMed Web of Science ®Google Scholar
• Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA. 2007;104(9):3432–3437.
   PubMed Web of Science ®Google Scholar
• Dey N, Das F, Mariappan MM, et al. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem. 2011;286(29):25586–25603.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhang Y, Wang Z, et al. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am J Nephrol. 2010;32(6):581–589.
   PubMed Web of Science ®Google Scholar
• Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. JASN. 2012;23(2):252–265.
   Web of Science ®Google Scholar
• Zhang Z, Luo X, Ding S, et al. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 2012;586(1):20–26.
   PubMed Web of Science ®Google Scholar
• Xu H, Yu S, Yuan X, et al. DACH1 suppresses breast cancer as a negative regulator of CD44. Sci Rep. 2017;7(1):4361.
   PubMedGoogle Scholar
• Kottgen A, Pattaro C, Boger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5):376–384.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li A, Yu S, et al. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis. J Hematol Oncol. 2018;11(1):53.
   PubMedGoogle Scholar
• Zhu J, Wu C, Li H, et al. DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3. Tumor Biol. 2016;37(7):9781–9788.
   PubMedGoogle Scholar
• Ma RC, Lee HM, Lam VK, et al. Familial young-onset diabetes, pre-diabetes and cardiovascular disease are associated with genetic variants of DACH1 in Chinese. PLoS One. 2014;9(1):e84770.
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. JASN. 2006;17(2):368–377.
   Web of Science ®Google Scholar
• Navarro JF, Mora C, Macıéa M, et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis. 2003;42(1):53–61.
   PubMed Web of Science ®Google Scholar
• Ying Q, Wu G. Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update. Ren Fail. 2017;39(1):474–483.
   PubMed Web of Science ®Google Scholar
• Tian H, Yang J, Xie Z, et al. Gliquidone alleviates diabetic nephropathy by inhibiting notch/snail signaling pathway. Cell Physiol Biochem. 2018;51(5):2085–2097.
   PubMedGoogle Scholar
• Copeland JW, Beaumont BW, Merrilees MJ, et al. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation. 2007;83(6):809–814.
   PubMed Web of Science ®Google Scholar
• Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, et al. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant. 1997;12(1):43–50.
   PubMed Web of Science ®Google Scholar
• Ng YY, Fan JM, Mu W, et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant. 1999;14(12):2860–2872.
   PubMed Web of Science ®Google Scholar
• Zhang W, Miao J, Ma C, et al. beta-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells. Peptides. 2012;36(2):186–191.
   PubMed Web of Science ®Google Scholar
• Kang MK, Park SH, Choi YJ, et al. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J Mol Med. 2015;93(7):759–772.
   PubMed Web of Science ®Google Scholar